A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of repeated daily administration of
rifampicin on the pharmacokinetics (what the body does to the medication) of abiraterone
following single-dose administration of abiraterone acetate tablets in healthy male
participants.